SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Rao V. Traumatic brain injury. In: LyketsosCG, RabinPV, LipseyJR et al., eds. Psychiatric Aspects of Neurologic Diseases. New York: Oxford University Press, 2008; 84100.
  • 2
    Sudarsanan BS, Chaudhary LCS, Pawar SCAA et al. Psychiatric effects of traumatic brain injury. Med J Armed Forces India 2006; 62: 259263.
  • 3
    Iwasaki K, Maruyama M, Tomita N et al. Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies. J Clin Psychiatry 2005; 66: 16121613.
  • 4
    Iwasaki K, Satoh-Nakagawa T, Maruyama M et al. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. J Clin Psychiatry 2005; 66: 248252.
  • 5
    Mizukami K, Asada T, Kinoshita T et al. A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia. Int J Neuropsychopharmacol 2009; 12: 191199.
  • 6
    Shinno H, Utani E, Okazaki S et al. Successful treatment with Yi-Gan San for psychosis and sleep disturbance in a patient with dementia with Lewy bodies. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 15431545.
  • 7
    Shinno H, Inami Y, Inagaki T et al. Effect of Yi-Gan San on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementia. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 881885.
  • 8
    Monji A, Takita M, Samejima T et al. Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 308311.
  • 9
    Miyaoka T, Furuya M, Yasuda H et al. Yi-gan san for the treatment of borderline personality disorder: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 150154.
  • 10
    Kawakami Z, Kanno H, Ueki T et al. Neuroprotective effects of yokukansan, a traditional Japanese medicine, on glutamate-mediated excitotoxicity in cultured cells. Neuroscience 2009; 159: 13971407.
  • 11
    Tateno M, Ukai W, Ono T et al. Neuroprotective effects of Yi-Gan San against beta amyloid-induced cytotoxicity on rat cortical neurons. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 17041707.
  • 12
    Sekiguchi K, Yamaguchi T, Tabuchi M et al. Effects of yokukansan, a traditional Japanese medicine, on aggressiveness induced by intracerebroventricular injection of amyloid beta protein into mice. Phytother Res 2009; 23: 11751181.
  • 13
    Egashira N, Iwasaki K, Ishibashi A et al. Repeated administration of yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT) 2A receptors in the prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 15161520.
  • 14
    Igarashi Y. Elucidation of the pharmacological mechanism of yokukansan. Geriatr Med 2008; 46: 255261 (in Japanese).
  • 15
    Mukai N, Kurauchi N, Suzuki S et al. Trial of yokukansan for postoperative delirium. Hokkaido Gerka Zasshi 2008; 53: 9091 (in Japanese).